Abstract: The present invention relates to infant nutrition, in particular to infant nutrition comprising special lipid globules for improvement of the fatty acid composition in brain membranes.
Type:
Grant
Filed:
September 8, 2016
Date of Patent:
February 4, 2020
Assignee:
N.V. NUTRICIA
Inventors:
Eline Marleen Van Der Beek, Marieke Abrahamse-Berkeveld, Annemiek Lidewij Schipper, Gelske Speelmans
Abstract: The present invention relates to the field of prebiotics. Provided are uses for compositions comprising synergistically effective amounts of polyfructose and galactooligosaccharides (GOS).
Type:
Application
Filed:
September 27, 2019
Publication date:
January 23, 2020
Applicant:
N.V. Nutricia
Inventors:
Gelske SPEELMANS, Maria Johanna Adriana Petronella GOVERS, Jan KNOL, Eric Alexander Franciscus VAN TOL
Abstract: The invention relates to a combination of a pyrimidine derivative and a fatty acid source for use in the treatment of constipation, in particular in the treatment of constipation in patients suffering from GI disorders, neurological disorders, or psychiatric disorders. Advantageously, the combination comprises one or more vitamins or fibres.
Abstract: The invention relates to a free glycine source for use in inducing tolerance against an allergen, or preventing the development of allergy in a human or other mammal. The invention further relates to a composition comprising protein, fat and carbohydrates with at least 7 en % protein and at least 60 mg free glycine source per gram protein, preferably at least 70 mg glycine per gram protein. The free glycine source is preferably the free amino acid glycine, a salt of the free amino acid glycine, or a combination thereof; the protein can be intact protein, hydrolysed protein, peptides, free amino acids, salts of amino acids, or combinations thereof.
Abstract: The invention concerns a method for stimulating barrier integrity in a mammal by administering to a mammal a composition comprising: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (ARA), and at least two distinct oligosaccharides.
Type:
Grant
Filed:
June 15, 2015
Date of Patent:
December 10, 2019
Assignee:
N.V. NUTRICIA
Inventors:
Eric Alexander Franciscus Van Tol, Linette Eustachia Maria Willemsen, Marleen Antoinette Koetsier, Christopher Beermann, Bernd Stahl
Abstract: The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter; (b) at least 12 wt % of leucine, based on total proteinaceous matter; (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid; (d) an immune modulator; for improving the immune function in a mammal, preferably a human.
Type:
Grant
Filed:
September 15, 2014
Date of Patent:
October 22, 2019
Assignee:
N. V. Nutricia
Inventors:
Joyce Faber, Adrianus Lambertus Bertholdus Van Helvoort, Klaske Van Norren, Arjan Paul Vos, Robert Johan Joseph Hageman, Cornelus Johannes Petrus Van Limpt
Abstract: Cereal-based semi-liquid and/or semi-solid compositions suitable for supporting the transition period wherein the infant changes from a diet consisting of breast milk or liquid infant formula to solid adult foods, comprising uronic acid carbohydrates with a degree of polymerization (DP) between 10 and 300 and also uses thereof are disclosed.
Type:
Grant
Filed:
May 31, 2016
Date of Patent:
October 15, 2019
Assignee:
N. V. NUTRICIA
Inventors:
Bernd Stahl, Martine Sandra Alles, Brigitte Antonia Maria Borgmann
Abstract: A packaging is disclosed for a powdered material comprising a tub for receiving the material, the tub having a base and a peripheral wall with a top edge; an outer sleeve around at least the peripheral wall of the tub, thereby supporting the tub; a removable membrane for separating the powdered material in the tub from the environment; and a lid assembly comprising a peripheral rim for connection over the top edge of the peripheral wall of the tub and defining a wide access opening and a lid, hingedly attached to the rim for reclosing the access opening. Furthermore, a method of manufacturing a package for a powdered material is disclosed, comprising sliding the tub in the sleeve, such that at least the peripheral wall of the tub is enclosed by the sleeve, whereby the sleeve supports the tub and the tub and sleeve form a container for the powdered material.
Type:
Application
Filed:
June 18, 2019
Publication date:
October 3, 2019
Applicant:
N.V. Nutricia
Inventors:
Alexander Josephus Maricus van Puijenbroek, Patrick Michael van Baal, Sjors Floris Crusius, Priya Caroline Roberts, Benoît Marie François Piette, Gary John Burdett
Abstract: The present invention relates to the field of prebiotics. Provided are uses for compositions comprising synergistically effective amounts of polyfructose and galactooligosaccharides (GOS).
Type:
Grant
Filed:
July 11, 2017
Date of Patent:
October 1, 2019
Assignee:
N.V. Nutricia
Inventors:
Gelske Speelmans, Maria Johanna Adriana Petronella Govers, Jan Knol, Eric Alexander Franciscus Van Tol
Abstract: An early in life nutritional intervention with a lipid component having both large lipid globules with phospholipids and an increased amount of palmitic acid in the sn-2 position in triglycerides were found to improve the fatty acid composition of cell membranes, in particular brain membranes.
Type:
Application
Filed:
June 7, 2019
Publication date:
September 26, 2019
Applicant:
N.V. Nutricia
Inventors:
Anniek Lidewij Schipper, Eline Marleen VAN DER BEEK, Dennis Stanley ACTON, Nana BARTKE, Stefanie SCHOEN
Abstract: The invention relates to a new strain of Lactobacillus salivarius, products containing the new strain, the use thereof in and methods for the treatment and/or prevention of inflammation and/or infection in breast or udder tissue, particularly in a mammary gland of a human female. The inflammation and/or infection is preferably mastitis.
Type:
Grant
Filed:
December 19, 2014
Date of Patent:
September 24, 2019
Assignee:
N.V. NUTRICIA
Inventors:
Rocio Martin, Jan Knol, Leonides Fernández Álvarez, Irene Espinosa Martos, Esther Antonia Jiménez Quintana, Juan Miguel Rodríguez Gómez
Abstract: Nutritional compositions with fucosyllactose and betagalactooligosaccharides for use in stimulation of the immune system. The composition is suitable for infants.
Type:
Grant
Filed:
November 23, 2016
Date of Patent:
September 24, 2019
Assignee:
N.V. NUTRICIA
Inventors:
Bernd Stahl, Alma Jildou Nauta, Johan Garssen, Eric Samain, Sophie Drouillard
Abstract: A container for a powdered nutritional product is provided, the container comprising a can having a base and an upstanding sidewall defining an interior space, the sidewall extending to a rim defining an opening to the interior space, a seal attached to the rim and serving to sealingly close the opening, wherein the seal is provided with a scoop recess formed between the seal and a blister element connected to the seal. Additionally, a lid is provided having an upper part and a lower part, wherein the lower part has a greater radius than the upper part, and wherein the radius of the upper part is smaller than the radius of the rim of the can.
Type:
Application
Filed:
October 25, 2017
Publication date:
August 22, 2019
Applicant:
N.V. Nutricia
Inventors:
Wido van Drecht, Maria Bernabe Betancor
Abstract: A packaging for a powdered material includes a tub for receiving the material, the tub having a base and a peripheral wall with a top edge; an outer sleeve around at least the peripheral wall of the tub, thereby supporting the tub; a removable membrane for separating the powdered material in the tub from the environment; and a lid assembly having a peripheral rim for connection over the top edge of the peripheral wall of the tub and defining a wide access opening and a lid, hingedly attached to the rim for reclosing the access opening. A method of manufacturing such a package for a powdered material includes sliding the tub in the sleeve, such that at least the peripheral wall of the tub is enclosed by the sleeve, whereby sleeve supports the tub and the tub and sleeve form a container for the powdered material.
Type:
Grant
Filed:
November 27, 2013
Date of Patent:
July 9, 2019
Assignee:
N.V. Nutricia
Inventors:
Alexander Josephus Maricus Van Puijenbroek, Patrick Michael Van Baal, Sjors Floris Crusius, Priya Caroline Roberts, Benoit Marie Francois Piette, Gary John Burdett
Abstract: The invention pertains to the use of soluble sodium in the manufacture of a composition or kit of parts for (therapeutically) improving and prolonging blood plasma uridine levels and tissue availability of uridine, and/or for treating or preventing impaired blood plasma uridine levels and tissue availability of uridine, and/or for preventing/treating disorders associated with impaired blood plasma and tissue availability of uridine, in a mammal, preferably a human being, by orally co-administering soluble sodium and uridine in a molar ratio of soluble sodium to uridine of more than 1:1, preferably more than 1.5:1, more preferably more than 2:1, even more preferably at least 2.5:1, even more preferably at least 2.8:1, more preferably 3:1-15:1, most preferably 3:1-10:1, particularly 3:1-5:1.
Abstract: To improve the solubility and the speed of dissolution of nutritional tablets comprising protein, fat and carbohydrates, dietary fibers are included in the nutritional tablets.
Type:
Grant
Filed:
October 19, 2016
Date of Patent:
June 18, 2019
Assignee:
N.V. Nutricia
Inventors:
Maarten Anne Hoijer, Anneke Maria Fransiska Olde Riekerink
Abstract: The invention pertains to the use of therapeutically effective amounts of (i) vitamin A and/or functional equivalents, (ii) vitamin D and/or functional equivalents, and (iii) at least one omega-3 PUFA, preferably DHA and/or EPA, more preferably DHA and EPA, for the manufacture of a composition or medicament for treating, reducing and/or preventing neuroinflammation and/or symptoms associated with neuroinflammation in a subject in need thereof, as well as for reducing microglia activation, and/or for treating, reducing and/or preventing symptoms associated with excessive activation of microglia; and/or for reducing the secretion of inflammatory cytokines, preferably IL-6, and/or for treating, reducing and/or preventing symptoms associated with excessive secretion of inflammatory cytokines, in a subject in need thereof.
Type:
Application
Filed:
June 9, 2017
Publication date:
June 13, 2019
Applicant:
N.V. NUTRICIA
Inventors:
Sofia LOPES DA SILVA, Ladislaus Maria BROERSEN, Robert Johan Joseph HAGEMAN, Jan Maarten VERKUIJL
Abstract: The invention pertains to a process for simultaneous producing an infant formula product and a dairy product from defatted animal milk, comprising (a) processing the milk into a casein stream, a whey protein stream and a lactose stream by a combination of microfiltration and ultrafiltration, wherein the casein stream originates from the microfiltration as retentate, the whey protein stream originates from the ultrafiltration as retentate and the lactose stream originates from the ultrafiltration as permeate; (b) combining at least part of the whey protein stream originating from step (a) and a lactose source to obtain are combined stream; (c) using the recombined stream originating from step (b) in the manufacture of the infant formula product; and (d) using at least part of the casein stream originating from step (a) and defatted animal milk in the manufacture of the dairy product.